HCG — Class III drug recall D-0436-2017
Terminated recall by Town and Country Compounding and Consultation Services, LLC, reported 2017-01-25, distributed nationwide. Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).
| Recall number | D-0436-2017 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Town and Country Compounding and Consultation Services, LLC, Ridgewood, NJ, United States |
| Recall initiated | 2016-10-18 |
| Classified | 2017-01-19 |
| Reported by FDA | 2017-01-25 |
| Terminated | 2021-01-14 |
| Distributed | Nationwide (US) |
| Quantity | 101 vials |
| Reason classes | potency |
Product
HCG (Chorionic Gonadotropin Lyopholized) II, 1000 unit vial, Rx only, Prepared by Town & Country, Compounding & Consultation Services, 106 Prospect St - 1st FL, Ridgewood, NJ 07459
Reason for recall
Subpotent Drug: due to failed potency results of 74% (spec. 80-125%).
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0436-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.